New look at PrEP study points to efficacy for transgender women
In a new look at the groundbreaking iPrEx trial for people at high risk of HIV infection, UC San Francisco researchers have identified strong evidence of efficacy for transgender women when PrEP, a two-drug antiretroviral ...
Nov 6, 2015
0
33